Literature DB >> 24295969

First report of macrolide resistance in a Mycoplasma pneumoniae isolate causing community-acquired pneumonia in Spain.

Juan de Dios Caballero1, Rosa del Campo, María Del Carmen Mafé, María Gálvez, Mario Rodríguez-Domínguez, Rafael Cantón, María Antonia Meseguer, José Manuel Hermida.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24295969      PMCID： PMC3910810          DOI： 10.1128/AAC.02325-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  10 in total

1.  Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011.

Authors:  S A Uldum; J M Bangsborg; B Gahrn-Hansen; R Ljung; M Mølvadgaard; R Føns Petersen; C Wiid Svarrer
Journal:  Euro Surveill       Date:  2012-02-02

2.  Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany.

Authors:  R Dumke; H von Baum; P C Lück; E Jacobs
Journal:  Clin Microbiol Infect       Date:  2009-09-17       Impact factor: 8.067

3.  Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children.

Authors:  Takafumi Okada; Miyuki Morozumi; Takeshi Tajima; Maki Hasegawa; Hiroshi Sakata; Shigeru Ohnari; Naoko Chiba; Satoshi Iwata; Kimiko Ubukata
Journal:  Clin Infect Dis       Date:  2012-09-12       Impact factor: 9.079

4.  Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae in respiratory specimens collected between 1997 and 2008 in The Netherlands.

Authors:  Emiel B M Spuesens; Adam Meijer; Damien Bierschenk; Theo Hoogenboezem; Gé A Donker; Nico G Hartwig; Marion P G Koopmans; Cornelis Vink; Annemarie M C van Rossum
Journal:  J Clin Microbiol       Date:  2012-04-11       Impact factor: 5.948

Review 5.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 6.  Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia.

Authors:  Miyuki Morozumi; Takashi Takahashi; Kimiko Ubukata
Journal:  J Infect Chemother       Date:  2010-01-22       Impact factor: 2.211

7.  Differences in the frequency of 23S rRNA gene mutations in Mycoplasma pneumoniae between children and adults with community-acquired pneumonia: clinical impact of mutations conferring macrolide resistance.

Authors:  Soo Jin Yoo; Hyo-Bin Kim; Sang-Ho Choi; Sang-Oh Lee; Sung-Han Kim; Sang-Bum Hong; Heungsup Sung; Mi-Na Kim
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

8.  Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis.

Authors:  O Peuchant; A Ménard; H Renaudin; M Morozumi; K Ubukata; C M Bébéar; S Pereyre
Journal:  J Antimicrob Chemother       Date:  2009-05-09       Impact factor: 5.790

9.  Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012.

Authors:  Fei Zhao; Gang Liu; Jiang Wu; Bin Cao; Xiaoxia Tao; Lihua He; Fanliang Meng; Liang Zhu; Min Lv; Yudong Yin; Jianzhong Zhang
Journal:  Antimicrob Agents Chemother       Date:  2012-12-21       Impact factor: 5.191

10.  Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis.

Authors:  Bernard J Wolff; W Lanier Thacker; Stephanie B Schwartz; Jonas M Winchell
Journal:  Antimicrob Agents Chemother       Date:  2008-07-21       Impact factor: 5.191
  10 in total
  6 in total

Review 1.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

Review 2.  Epidemiology of Mycoplasma pneumoniae Infections in Japan and Therapeutic Strategies for Macrolide-Resistant M. pneumoniae.

Authors:  Tsutomu Yamazaki; Tsuyoshi Kenri
Journal:  Front Microbiol       Date:  2016-05-23       Impact factor: 5.640

3.  Antimicrobial susceptibility and molecular characteristics of Mycoplasma pneumoniae isolates across different regions of China.

Authors:  Fei Zhao; Jing Li; Jinrong Liu; Xuemei Guan; Jie Gong; Liyong Liu; Lihua He; Fanliang Meng; Jianzhong Zhang
Journal:  Antimicrob Resist Infect Control       Date:  2019-08-23       Impact factor: 4.887

4.  Antimicrobial susceptibility and genotyping of Mycoplasma pneumoniae isolates in Beijing, China, from 2014 to 2016.

Authors:  Fei Zhao; Jinrong Liu; Weixian Shi; Fang Huang; Liyong Liu; Shunying Zhao; Jianzhong Zhang
Journal:  Antimicrob Resist Infect Control       Date:  2019-01-24       Impact factor: 4.887

Review 5.  Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association.

Authors:  Bin Cao; Yi Huang; Dan-Yang She; Qi-Jian Cheng; Hong Fan; Xin-Lun Tian; Jin-Fu Xu; Jing Zhang; Yu Chen; Ning Shen; Hui Wang; Mei Jiang; Xiang-Yan Zhang; Yi Shi; Bei He; Li-Xian He; You-Ning Liu; Jie-Ming Qu
Journal:  Clin Respir J       Date:  2017-09-26       Impact factor: 2.570

Review 6.  Community-acquired pneumonia: An overview.

Authors:  Lionel A Mandell
Journal:  Postgrad Med       Date:  2015-08       Impact factor: 3.840
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.